Sippel, Anna
Scheiderbauer, Jutta
Eklund, Désirée
Arnade, Sigrid
Schmidt, Stephan
Kleiter, Ingo
Morrison, Rebecca
Kofahl, Christopher
Heesen, Christoph
Funding for this research was provided by:
Roche Pharma AG
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 25 August 2021
Accepted: 30 March 2022
First Online: 20 April 2022
Declarations
:
: This study has been performed in accordance with the Declaration of Helsinki. Ethical approval has been obtained from the ethical committee of the Hamburg Chamber of Physicians (approval number: PV5770). Informed consent to participate in the study was obtained from all patients and experts. All procedures were performed in accordance with the Helsinki Declaration.
: Informed consent to publish research findings was obtained from all patients and experts.
: AS and CH are developers of the website. AS has received funding from Roche Pharma and salaries for talks from Novartis. CH has received research grants, congress travel compensations and salaries for talks from Biogen, Genzyme, Sanofi-Aventis, Bayer Healthcare, Merck, Teva Pharma, Roche Pharma, and Novartis. IK has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alexion, Biogen, Celgene, Chugai, IQVIA, Merck, Mylan, Novartis, Roche, Sanofi. SSch has received fees for consulting and reimbursement for lecturing as well as attending symposia from Bayer Vital, Biogen, Merck, Roche, Genzyme and Teva. He has also received research funding from Bayer Vital and Merck. JS, DE, SA, RM, CK declare that they have no competing interests.